Century Therapeutics Inc (IPSC) — Long-term Investment Intensity

Latest as of March 2026: 25.2%

Century Therapeutics Inc (IPSC) has a Long-term Investment Intensity of 25.2% as of March 2026. Long-term investments of $82.17 Million represent 25.2% of total assets of $326.55 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check IPSC asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

25.2%
LT Investments / Total Assets

Long-term Investments

$82.17 Million
USD

Total Assets

$326.55 Million
USD

Country

USA
NASDAQ

Century Therapeutics Inc Long-term Investment Intensity (2019–2024)

This chart shows how Century Therapeutics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2024. As of March 2026, the intensity stands at 25.2%, reflecting long-term investments of $82.17 Million against total assets of $326.55 Million USD. For the complete balance sheet picture, see how large is Century Therapeutics Inc's balance sheet.

Annual Long-term Investment Intensity for Century Therapeutics Inc (2019–2024)

The table below presents the year-by-year Long-term Investment Intensity for Century Therapeutics Inc from 2019 to 2024, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Century Therapeutics Inc for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2024 8.7% $30.82 Million $353.22 Million ▼ -16.0 pp
2023 24.7% $89.10 Million $360.69 Million ▲ +14.0 pp
2022 10.7% $51.85 Million $486.54 Million ▼ -20.4 pp
2021 31.1% $135.91 Million $437.38 Million ▲ +30.1 pp
2020 1.0% $1.05 Million $106.78 Million ▼ -3.5 pp
2019 4.5% $4.08 Million $90.90 Million
pp = percentage points